Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors

Cell Death Dis. 2023 Sep 7;14(9):597. doi: 10.1038/s41419-023-06123-1.

Abstract

Insulin signaling often plays a role in the regulation of cancer, including tumor initiation, progression, and response to treatment. In addition, the insulin-regulated PI3K-Akt-mTOR pathway plays an important role in the regulation of islet cell proliferation, and this pathway is hyperactivated in human non-functional pancreatic neuroendocrine tumors (PanNETs). We, therefore, investigated the effect of a very low carbohydrate diet (ketogenic diet) on a mouse model that develops non-functional PanNETs to ask how reduced PI3K-Akt-mTOR signaling might affect the development and progression of non-functional PanNET. We found that this dietary intervention resulted in lower PI3K-Akt-mTOR signaling in islet cells and a significant reduction in PanNET formation and progression. We also found that this treatment had a significant effect on the suppression of pituitary NET development. Furthermore, we found that non-functional PanNET patients with lower blood glucose levels tend to have a better prognosis than patients with higher blood glucose levels. This preclinical study shows that a dietary intervention that results in lower serum insulin levels leads to lower insulin signals within the neuroendocrine cells and has a striking suppressive effect on the development and progression of both pancreatic and pituitary NETs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose
  • Diet, Carbohydrate-Restricted
  • Humans
  • Insulin
  • Mice
  • Neuroendocrine Tumors*
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Receptor Protein-Tyrosine Kinases
  • TOR Serine-Threonine Kinases

Substances

  • Blood Glucose
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Insulin
  • TOR Serine-Threonine Kinases
  • Receptor Protein-Tyrosine Kinases